Table 2.

Effect of CoQ₁₀ supplementation on serum ubiquinone and creatine kinase levels in Statin-treated obese rats

Group	Ubiquinone (ng/ml)	Creatine kinase (U/L)
N	<20.00	400.10 ± 43.57$$
NSC270	71.00 ± 5.46	410.90 ± 39.13$$
H	<20.00	554.60 ± 31.51
HS	<20.00	652.40 ± 36.40**
HC	148.90 ± 13.32	529.20 ± 59.65
HSC30	35.33 ± 2.98	593.20 ± 46.04**
HSC90	60.89 ± 4.32	570.70 ± 50.34
HSC270	85.11 ± 6.50	462.56 ± 52.38$$

Values are means ± S.E. (n=10).

^**p<0.01 vs. normal diet group,

^$$p<0.01 vs. high-fat diet with Statin group. N: normal diet group, NSC270: normal diet with Statin and CoQ₁₀ (270 mg/kg) group, H: high-fat diet group, HS: high-fat diet with Statin group, HC: high-fat diet with CoQ₁₀ (270 mg/kg) group, and HSC30, HSC90, HSC270: high-fat diet with Statin and CoQ₁₀ at various doses (30, 90 or 270 mg/kg) group.